Nano Labs Ltd
NA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.64 | 0.17 | -0.50 | -0.62 |
| FCF Yield | -3.99% | -3.16% | -8.09% | 0.16% |
| EV / EBITDA | -45.20 | -31.52 | 19.93 | -233.83 |
| Quality | ||||
| ROIC | -22.82% | -193.71% | 16.95% | 1,040.64% |
| Gross Margin | 28.58% | -132.06% | 23.41% | -10.37% |
| Cash Conversion Ratio | 1.17 | 0.52 | -8.84 | -0.41 |
| Growth | ||||
| Revenue 3-Year CAGR | -65.44% | 25.70% | 673.23% | – |
| Free Cash Flow Growth | 26.47% | 30.08% | -642.14% | 1,690.05% |
| Safety | ||||
| Net Debt / EBITDA | -1.65 | -0.42 | -0.31 | 1.34 |
| Interest Coverage | -14.25 | -283.45 | 0.00 | -350.72 |
| Efficiency | ||||
| Inventory Turnover | 0.97 | 14.12 | 7.37 | 0.20 |
| Cash Conversion Cycle | 610.28 | 0.07 | 50.94 | 2,075.60 |